240 related articles for article (PubMed ID: 18790190)
1. Heat inactivation can differentiate between IgG and IgM antibodies in the pretransplant cross match.
Al-Muzairai IA; Mansour M; Almajed L; Alkanderi N; Alshatti N; Samhan M
Transplant Proc; 2008 Sep; 40(7):2198-9. PubMed ID: 18790190
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Crossmatching technique facilitating kidney transplantation.
Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin class (IgG, IgM) determination by dithiothreitol in sensitized kidney transplant candidates.
Khodadadi L; Adib M; Pourazar A
Transplant Proc; 2006 Nov; 38(9):2813-5. PubMed ID: 17112836
[TBL] [Abstract][Full Text] [Related]
5. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
Shoker A; Klassen J; Herbut B
Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
[TBL] [Abstract][Full Text] [Related]
7. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
8. Is positive flow cytometric cross-match a risk factor for early cadaveric kidney graft dysfunction?
Piatosa B; Rubik J; Grenda R
Transplant Proc; 2006; 38(1):53-5. PubMed ID: 16504662
[TBL] [Abstract][Full Text] [Related]
9. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
[TBL] [Abstract][Full Text] [Related]
10. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.
Przybylowski P; Balogna M; Radovancevic B; Frazier OH; Susskind B; Van Buren C; Katz S; Kahan BD; Kerman R
Transplantation; 1999 Jan; 67(2):258-62. PubMed ID: 10075590
[TBL] [Abstract][Full Text] [Related]
11. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts.
Daniel V; Sadeghi M; Suesal C; Scherer S; Tran H; Gombos P; Trojan K; Morath C; Opelz G
Clin Transplant; 2016 Feb; 30(2):124-30. PubMed ID: 26537026
[TBL] [Abstract][Full Text] [Related]
14. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports.
Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E
Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254
[TBL] [Abstract][Full Text] [Related]
15. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity.
Scornik JC; Brunson ME; Schaub B; Howard RJ; Pfaff WW
Transplantation; 1994 Feb; 57(4):621-5. PubMed ID: 8116050
[TBL] [Abstract][Full Text] [Related]
16. Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates.
Lobashevsky A; Rosner K; Goggins W; Higgins N
Transpl Immunol; 2010 May; 23(1-2):81-5. PubMed ID: 20304065
[TBL] [Abstract][Full Text] [Related]
17. [Can one graft with a positive cross-match?].
Alamartine E; Acquart S; Absi L; Diab N; de Filippis JP; Le Petit JC; Berthoux F
Nephrologie; 1997; 18(5):175-80. PubMed ID: 9424594
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin-G subclass antidonor reactivity in transplant recipients.
Gao ZH; McAlister VC; Wright JR; McAlister CC; Peltekian K; MacDonald AS
Liver Transpl; 2004 Aug; 10(8):1055-9. PubMed ID: 15390333
[TBL] [Abstract][Full Text] [Related]
19. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
[TBL] [Abstract][Full Text] [Related]
20. Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation.
McAlister CC; Gao ZH; McAlister VC; Gupta R; Wright JR; MacDonald AS; Peltekian K
Liver Transpl; 2004 Feb; 10(2):315-9. PubMed ID: 14762873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
